92 related articles for article (PubMed ID: 29855452)
21. Prevention of nonvertebral fractures by alendronate. A meta-analysis. Alendronate Osteoporosis Treatment Study Groups.
Karpf DB; Shapiro DR; Seeman E; Ensrud KE; Johnston CC; Adami S; Harris ST; Santora AC; Hirsch LJ; Oppenheimer L; Thompson D
JAMA; 1997 Apr; 277(14):1159-64. PubMed ID: 9087473
[TBL] [Abstract][Full Text] [Related]
22. Effect of alendronate for reducing fracture by FRAX score and femoral neck bone mineral density: the Fracture Intervention Trial.
Donaldson MG; Palermo L; Ensrud KE; Hochberg MC; Schousboe JT; Cummings SR
J Bone Miner Res; 2012 Aug; 27(8):1804-10. PubMed ID: 22492479
[TBL] [Abstract][Full Text] [Related]
23. Comparative effectiveness of osteoporosis drugs in preventing secondary nonvertebral fractures in Taiwanese women.
Lin TC; Yang CY; Yang YH; Lin SJ
J Clin Endocrinol Metab; 2013 Dec; 98(12):4717-26. PubMed ID: 24081731
[TBL] [Abstract][Full Text] [Related]
24. Pretreatment levels of bone turnover and the antifracture efficacy of alendronate: the fracture intervention trial.
Bauer DC; Garnero P; Hochberg MC; Santora A; Delmas P; Ewing SK; Black DM;
J Bone Miner Res; 2006 Feb; 21(2):292-9. PubMed ID: 16418785
[TBL] [Abstract][Full Text] [Related]
25. Notice of retraction.
Acta Anaesthesiol Scand; 2013 Jan; 57(1):133. PubMed ID: 23216363
[TBL] [Abstract][Full Text] [Related]
26. Indirect comparison of teriparatide, denosumab, and oral bisphosphonates for the prevention of vertebral and nonvertebral fractures in postmenopausal women with osteoporosis.
Zhang L; Pang Y; Shi Y; Xu M; Xu X; Zhang J; Ji L; Zhao D
Menopause; 2015 Sep; 22(9):1021-5. PubMed ID: 25944523
[TBL] [Abstract][Full Text] [Related]
27. Statement of Concern Regarding: Sato Y, Iwamoto J, Kanoko T, Satoh K. Homocysteine as a Predictive Factor for Hip Fracture in Elderly Women with Parkinson's Disease. Am J Med. 2005;118:1250-1255.
Alpert JS
Am J Med; 2018 Mar; 131(3):e109. PubMed ID: 29454423
[No Abstract] [Full Text] [Related]
28. Etidronate and alendronate in the treatment of postmenopausal osteoporosis.
Beauchesne MF; Miller PF
Ann Pharmacother; 1999 May; 33(5):587-99. PubMed ID: 10369624
[TBL] [Abstract][Full Text] [Related]
29. Comparative efficacy of bisphosphonates in short-term fracture prevention for primary osteoporosis: a systematic review with network meta-analyses.
Zhou J; Ma X; Wang T; Zhai S
Osteoporos Int; 2016 Nov; 27(11):3289-3300. PubMed ID: 27273112
[TBL] [Abstract][Full Text] [Related]
30. Whole-body vibration versus proprioceptive training on postural control in post-menopausal osteopenic women.
Stolzenberg N; Belavý DL; Rawer R; Felsenberg D
Gait Posture; 2013 Jul; 38(3):416-20. PubMed ID: 23375357
[TBL] [Abstract][Full Text] [Related]
31. Retraction notice to "Relationship between post-tetanic twitch and single twitch response after administration of vecuronium" [Br J Anaesth 1993; 71: 443-444].
Saitoh Y; Toyooka H; Amaha K
Br J Anaesth; 2019 Jan; 122(1):151. PubMed ID: 30579395
[TBL] [Abstract][Full Text] [Related]
32. From the History of the Croatian Dermatovenereological Society - The Croatian Medical Association and an Overview of Important Information Regarding the Journal Acta Dermatovenerologica Croatica.
Dobrić I
Acta Dermatovenerol Croat; 2018 Dec; 26(4):344-348. PubMed ID: 30665489
[TBL] [Abstract][Full Text] [Related]
33. Balance training and exercise in geriatric patients.
Runge M; Rehfeld G; Resnicek E
J Musculoskelet Neuronal Interact; 2000 Sep; 1(1):61-5. PubMed ID: 15758528
[TBL] [Abstract][Full Text] [Related]
34. Retraction notice to "Post-tetanic burst: a new monitoring method for intense neuromuscular block" [Br J Anaesth 1995; 74: 293-295].
Saitoh Y; Toyooka H; Amaha K
Br J Anaesth; 2019 Jan; 122(1):154. PubMed ID: 30579398
[TBL] [Abstract][Full Text] [Related]
35. Retracted articles in surgery journals. What are surgeons doing wrong?
Cassão BD; Herbella FAM; Schlottmann F; Patti MG
Surgery; 2018 Jun; 163(6):1201-1206. PubMed ID: 29525734
[TBL] [Abstract][Full Text] [Related]
36. Retraction notice to "Effect of tetanic stimulation on subsequent train-of-four responses at various levels of vecuronium-induced neuromuscular block" [Br J Anaesth 1994; 73: 416-417].
Saitoh Y; Masuda A; Toyooka H; Amaha K
Br J Anaesth; 2019 Jan; 122(1):153. PubMed ID: 30579397
[TBL] [Abstract][Full Text] [Related]
37. Retraction notice to "Monitoring of neuromuscular block after administration of vecuronium in patients with diabetes mellitus" [Br J Anaesth 2003; 90: 480-486].
Saitoh Y; Kaneda K; Hattori H; Nakajima H; Murakawa M
Br J Anaesth; 2019 Jan; 122(1):156. PubMed ID: 30579400
[TBL] [Abstract][Full Text] [Related]
38. Retraction notice to "Infusion of amino acid enriched solution hastens recovery from neuromuscular block caused by vecuronium" [Br J Anaesth 2001; 86: 814-821].
Saitoh Y; Kaneda K; Tokunaga Y; Murakawa M
Br J Anaesth; 2019 Jan; 122(1):155. PubMed ID: 30579399
[TBL] [Abstract][Full Text] [Related]
39. Scientific misconduct. Cleaning up the paper trail.
Couzin J; Unger K
Science; 2006 Apr; 312(5770):38-43. PubMed ID: 16601164
[No Abstract] [Full Text] [Related]
40. Retraction notice to "Post-tetanic count and single twitch height at the onset of reflex movement after administration of vecuronium under different types of anaesthesia" [Br J Anaesth 1994; 72: 688-690].
Saitoh Y; Kaneda K; Toyooka H; Amaha K
Br J Anaesth; 2019 Jan; 122(1):152. PubMed ID: 30579396
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
